Delivery Order SPE2DB22D2006-SPE2DB25FW2WB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp in the amount of $30,397.69 for the supply of Isosulfan Blue 1% vials. This contract is a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical products and supplies to support military healthcare programs and facilities. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,446.89, is for the delivery of Isosulfan Blue 1% Vial 5ML medical supplies. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a $7,356.52 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4,566,185,907 units of 1% isosulfan blue dye vials (5 ml). This delivery order is a part of a larger indefinite delivery contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand one hundred eighty-five dollars and ninety-six cents ($30,185.96) to Amerisourcebergen Drug Corporation for 4561971256 Isosulfan Blue 1% Vial 5mL. The place of performance is Conshohocken, Pennsylvania. The order period of performance is from August 28, 2023 through August 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,356.52, is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML, a medical supply product. The contract has a firm fixed price and an ultimate completion date of August 15, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award, valued at $14,509.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isosulfan Blue 1% Vial, 5mL, a medical product used in various healthcare applications. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,502.14 firm fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML medical supplies. The contract, valued at $17,431.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a completion date of January 5, 2024, and it is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 18, 2025, for Methylene Blue 50 mg/10 mL vials with a ceiling value of $1,398.70. This competitive award, issued by the Defense Logistics Agency's Medical Supply Chain, carries a firm fixed price structure with an ultimate completion date of July 21, 2025. The place of performance is located at the contractor's corporate office in Conshohocken,...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB22FM1L0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,942.15 firm-fixed-price delivery order is for the supply of 4555811271 - ISOSULFAN BLUE 1% VIAL 5ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2WBDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Isosulfan Blue 1% vials (5ml) with a ceiling value of $30,946.99. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement extending through December 2026 that supports comprehensive pharmaceutical and medical supply needs for military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor providing critical medical commodities including specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Isosulfan blue is a diagnostic pharmaceutical used in medical procedures, consistent with the company's portfolio of specialized healthcare products delivered under this expansive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.9k | 7/25/25 |